"I'm going to say something super weird," Dame Emma Walmsley says, when asked about the moment an activist investor challenged her, halfway through her nine years as CEO of GSK: "I think I was lucky ...
Emma Walmsley has served as CEO of GlaxoSmithKline since 2017. From the Philadelphia Business Journal. GSK is making a change at the top. The London-based Big Pharma company, which has major ...
After nearly nine years as GSK’s CEO, Emma Walmsley exited on a high note as her total compensation for 2025 surged nearly 50% to 15.7 million pounds sterling ($21 million). This swan song payout, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results